24 results
Keyword Intrafer - Gocce Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Fertavid
follitropin beta, Infertility, Hypogonadism
Date of authorisation: 19/03/2009, Revision: 12, Withdrawn, Last updated: 23/06/2020 -
List item
Human medicine European public assessment report (EPAR): GONAL-f
follitropin alfa, Anovulation, Reproductive Techniques, Assisted, Infertility, Female, Hypogonadism
Date of authorisation: 20/10/1995, Revision: 23, Authorised, Last updated: 11/02/2020fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT). GONAL-f … -
List item
Human medicine European public assessment report (EPAR): Ovaleap
follitropin alfa, Anovulation
Date of authorisation: 27/09/2013,
, Revision: 9, Authorised, Last updated: 03/10/2019
fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer; Ovaleap in association … -
List item
Human medicine European public assessment report (EPAR): Bemfola
follitropin alfa, Anovulation
Date of authorisation: 26/03/2014,, Revision: 8, Authorised, Last updated: 10/01/2019
fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT); follitropin … -
List item
Human medicine European public assessment report (EPAR): Puregon
follitropin beta, Infertility, Hypogonadism
Date of authorisation: 02/05/1996, Revision: 30, Authorised, Last updated: 11/02/2021transfer (IVF/ET), gamete intrafallopian transfer (GIFT) and intracytoplasmic … -
List item
National expert: Antonio Battisti, Ministry for Health (updated)
- Declaration of interests - 79.92 KB | PDF
- Curriculum Vitae - 36.11 KB | PDF
-
List item
National expert: Giuseppe Indolfi, European Medicines Agency (updated)
- Declaration of interests - 80.62 KB | PDF
- Curriculum Vitae - 32.54 KB | PDF
M, de Martino M, Resti M. Intrafamilial Transmission of Hepatitis … -
List item
Human medicine European public assessment report (EPAR): Brineura (updated)
cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017,
, 
, 
, 
, Revision: 5, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Cetrotide
cetrorelix (as acetate), Ovulation, Ovulation Induction
Date of authorisation: 12/04/1999, Revision: 26, Authorised, Last updated: 19/12/2019embryo transfer and gamete intrafallopian transfer results in a lower … -
List item
Human medicine European public assessment report (EPAR): Elmiron
pentosan polysulfate sodium, Cystitis, Interstitial
Date of authorisation: 02/06/2017, Revision: 11, Authorised, Last updated: 21/09/2020 -
List item
Herbal medicinal product: Hamamelidis cortex
Hamamelis virginiana L., Hamamelis Bark, F: Assessment finalised, Last updated: 04/12/2019 -
List item
National expert: Astrid Thomas, European Medicines Agency (updated)
- Declaration of interests - 79.92 KB | PDF
- Curriculum Vitae - 51.94 KB | PDF
-
List item
Herbal medicinal product: Hamamelidis folium
Hamamelis virginiana L., Hamamelis Leaf, F: Assessment finalised, Last updated: 09/12/2019 -
List item
Herbal medicinal product: Hamamelidis folium et cortex aut ramunculus destillatum
Hamamelis virginiana L., Hamamelis Distillate, F: Assessment finalised, Last updated: 04/12/2019 -
List item
Direct healthcare professional communication (DHPC): Respreeza (human alpha-1-proteinase inhibitor): Sterility issue with the infusion device co-packed with Respreeza 4.000 mg and 5.000 mg (new)
Active substance: Human alpha1-proteinase inhibitor, DHPC type: Medicine shortage, Last updated: 26/03/2021alternative infusion set (BBraun Intrafix® Primeline Art. No. 4062981L … alternative infusion set (BBraun Intrafix® Primeline Art. No. 4062981L … -
List item
Referral: Zyrtec
cetirizine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2008, EC decision date: 06/10/2008, Last updated: 16/10/2008 -
List item
National expert: Rudy Van Coster, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 69.77 KB | PDF
-
List item
Referral: Intravenous iron-containing medicinal products
ferric carboxymaltose, iron dextran, sodium ferric gluconate, iron isomaltoside, iron sucrose, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 13/09/2013, Last updated: 22/03/2017 -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Human recombinant follicle-stimulating hormone (FE 999049)
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
PIP number: EMEA-001183-PIP02-13, Route(s) of administration: Subcutaneous use, Pharmaceutical form(s): Concentrate for solution for injection
Decision date: 08/08/2014, Last updated: 22/08/2014, Compliance check: Xtransfer (IVT/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic … -
List item
National expert: Dieter Deforce, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 79.92 KB | PDF
- Curriculum Vitae - 170.64 KB | PDF
-
List item
List of medicines under additional monitoring (updated)
Last updated: 31/03/2021 -
List item
Similar biological medicinal products containing recombinant follicle-stimulating hormone
Last updated: 06/03/2013 -
List item
Public data from Article 57 database
Last updated: 16/02/2021 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013